Choose a GLP-1 telehealth provider if you want supervised compounded semaglutide or tirzepatide with the prescription, dosing, and monitoring handled
GLP-1 Certification for Weight Loss Get trained in glp-1s and FDA-approved medical weight management treatments
Subcutaneous semaglutide 1.0 mg and oral semaglutide 14 mg resulted in weight reductions of 4.5 kg and 3.7 kg, respectively, while placebo only resulted in weight reductions of 1.0 kg and 1.4 kg, respectively
If you experience any of the following, remain at your current dose for an additional 2 to 4 weeks before escalating: Nausea lasting more than 3 days after injection Vomiting more than once per week Inability to maintain adequate caloric intake (under 1,000 calories daily) Signs of dehydration despite increased fluid intake New onset of significant fatigue that interferes with daily function Slowing escalation is not failure
Some are investing heavily in drug-device combinations, such as pre-filled injection pens that closely mirror branded products